Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Cerebral Arterial Diseases

fluorodeoxyglucose f18 has been researched along with Cerebral Arterial Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arnolda, LF; Beer, CD; Blacker, D; Hankey, GJ; Lenzo, N; Potter, K; Puddey, IB	1

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and Cerebral Arterial Diseases

Article	Year
Systemic arterial inflammation, measured with 18FDG-PET, is common amongst subjects with both recent and prior cerebrovascular disease. Clinical neurology and neurosurgery, 2012, Volume: 114, Issue:6 Topics: Aged; Arteritis; Blood Pressure; Brain Ischemia; Carotid Arteries; Case-Control Studies; Cerebral Arterial Diseases; Cerebrovascular Disorders; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Ischemic Attack, Transient; Lipids; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Stroke	2012

Article

Year

Systemic arterial inflammation, measured with 18FDG-PET, is common amongst subjects with both recent and prior cerebrovascular disease.

Clinical neurology and neurosurgery, 2012, Volume: 114, Issue:6

Topics: Aged; Arteritis; Blood Pressure; Brain Ischemia; Carotid Arteries; Case-Control Studies; Cerebral Arterial Diseases; Cerebrovascular Disorders; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Ischemic Attack, Transient; Lipids; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Stroke

2012